Stay updated on Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study record page now shows a 403 Forbidden error and minimal navigation (including a Home link), replacing the previous study content and metadata.SummaryDifference18%

- Check17 days agoChange DetectedThe page's revision label was updated from v3.6.6 to v3.7.0 in the footer. This reflects an update to the page software/versioning without changing the study details.SummaryDifference0.1%

- Check31 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a backend software update. This change does not appear to affect the study details or user-facing content on the page.SummaryDifference0.1%

- Check52 days agoChange DetectedResults Submitted is now shown, indicating that the study's results have been submitted and are reflected on the page. The record's revision tag advanced to v3.6.5, replacing the previous 'No Results Posted' status and v3.6.4.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, signaling a minor update to the page without changing the study information.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3. This indicates a small update to the page rather than new study information.SummaryDifference0.0%

Stay in the know with updates to Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.